Literature DB >> 26526931

Function of sustained released resveratrol on IL-1β-induced hBMSC MMP13 secretion inhibition and chondrogenic differentiation promotion.

Gang Wu1, Lei Wang2, Hong Li3, Yu Ke4, Yongchang Yao2.   

Abstract

Metalloproteinase-13 is the major type II collagenase that directly implicates cartilage matrix destruction. Metalloproteinase-13 is inducted and activated by interleukin-1β, which is a commonly observed proinflammatory cytokine in the joint cavity of arthritic patients. Depression of interleukin-1β function can inhibit metalloproteinase-13 expression and protect the cartilage extracellular matrix. In this study, resveratrol release microspheres were developed, and the direct function of the released resveratrol on the interleukin-1β was discussed. The resveratrol-loaded microspheres were fabricated using oil-in-water emulsion and solution-evaporation methods. The particle size and the encapsulation efficiency for the techniques, which used different fabrication conditions, were within 8.3-63.9 μm and 37%-82%, respectively. The effect of drug release lasted for more than 650 h in a PBS solution at 37℃. Human bone mesenchymal stem cells were chosen for cell experiments. Interleukin-1β was used to induce an inflammatory condition. The effect of sustained resveratrol release from the microspheres on the cells' gene expression was observed using the transwell co-culturing method. The results indicated that metalloproteinase-13 mRNA expression was upregulated after interleukin-1β induction. The released resveratrol directly inhibited the function of interleukin-1β and thus downregulated metalloproteinase-13 mRNA expression. Moreover, the upregulation of Col2, aggrecan and Sox9 mRNA expressions, which are major chondrocyte markers, was observed after resveratrol was released into the culture medium. Resveratrol was observed to maintain the cells' chondrogenic gene expression when subject to the inflammation condition. The sustained released resveratrol inhibited interleukin-1β-inducted metalloproteinase-13 activation and promoted chondrocyte differentiation. This drug-loading microsphere is a promising candidate for arthritis therapy.
© The Author(s) 2015.

Entities:  

Keywords:  Resveratrol; human bone mesenchymal stem cells; metalloproteinase-13; microsphere; sustained-release

Mesh:

Substances:

Year:  2015        PMID: 26526931     DOI: 10.1177/0885328215614425

Source DB:  PubMed          Journal:  J Biomater Appl        ISSN: 0885-3282            Impact factor:   2.646


  5 in total

1.  Sirtuin 1 regulates matrix metalloproteinase-13 expression induced by Porphyromonas endodontalis lipopolysaccharide via targeting nuclear factor-κB in osteoblasts.

Authors:  Liu Qu; Yaqiong Yu; Lihong Qiu; Di Yang; Lu Yan; Jiajie Guo; Rabita Jahan
Journal:  J Oral Microbiol       Date:  2017-04-21       Impact factor: 5.474

2.  Mesenchymal stem cell therapies for intervertebral disc degeneration: Consideration of the degenerate niche.

Authors:  Louise Vickers; Abbey A Thorpe; Joseph Snuggs; Christopher Sammon; Christine L Le Maitre
Journal:  JOR Spine       Date:  2019-06-26

Review 3.  Herbal Remedies as Potential in Cartilage Tissue Engineering: An Overview of New Therapeutic Approaches and Strategies.

Authors:  Constanze Buhrmann; Ali Honarvar; Mohsen Setayeshmehr; Saeed Karbasi; Mehdi Shakibaei; Ali Valiani
Journal:  Molecules       Date:  2020-07-06       Impact factor: 4.411

Review 4.  Protective Effect of Resveratrol on Knee Osteoarthritis and its Molecular Mechanisms: A Recent Review in Preclinical and Clinical Trials.

Authors:  Shenglei Yang; Mingli Sun; Xinan Zhang
Journal:  Front Pharmacol       Date:  2022-07-25       Impact factor: 5.988

Review 5.  Recent Overview of Resveratrol's Beneficial Effects and Its Nano-Delivery Systems.

Authors:  Raghvendra A Bohara; Nazish Tabassum; Mohan P Singh; Giuseppe Gigli; Andrea Ragusa; Stefano Leporatti
Journal:  Molecules       Date:  2022-08-12       Impact factor: 4.927

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.